Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury

FASEB Journal

Volumn 20, Issue 12, 2006, Pages

  McCormick, James ^a   Barry, Sean P ^a   Sivarajah, Ahila ^b   Stefanutti, Giorgio ^a   Townsend, Paul A ^c   Lawrence, Kevin M ^b   Eaton, Simon ^a   Knight, Richard A ^a   Thiemermann, Christoph ^b   Latchman, David S ^a   Stephanou, Anastasis ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Heart; Rat; Tempol

Indexed keywords

GAMMA INTERFERON; HISTONE H2AX; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TEMPOL; AMINE OXIDE; CARDIOTONIC AGENT; STAT1 PROTEIN, RAT; STAT3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPIN LABELING; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; CYCLIC N-OXIDES; FREE RADICAL SCAVENGERS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; RATS; RATS, WISTAR; SPIN LABELS; STAT TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 33845681986     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6188fje     Document Type: Article

References (25)

1. Maxwell, S. R, and Lip, G. Y. (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int. J. Cardiol. 58, 95-117
2. Eefting, F., Rensing, B., Wigman, J., Pannekoek, W. J., Liu, W. M., Cramer, M. J., Lips, D. J., and Doevendans P. A. (2004) Role of apoptosis in reperfusion injury. Cardiovasc. Res. 61, 414-426
3. Olivevetti, G., Quani, F., Sala, R., Lagrasta C., Corradi, D., Bonacina, E., Gambert, S. R, Cigoa, E., and Anvera, P. (1994) Acute myocardial infarction in humans is associated with the activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell. Cardiol. 28, 2005-2016
4. Stephanou, A., Brar, B. K., Scarabelli, T., Knight, R. A., and Latchman, D. S. (2001) Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes in ischaemia versus reperfusion injury, Cell Death Differentiation 2002 8, 434-435
5. Scarabelli, T. M, Stephanou, A., Pasini, E., Comini, L., Raddino, R., Knight, R A., and Latchman, D. S. (2002) Different signalling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischaemia/reperfusion injury. Circ. Res. 90, 745-748
6. Kukreja, R. C., and Hess, M. L. (1992) The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26, 641-655
7. Flaherty, J. T. (1991) Myocardial injury mediated by oxygen free radicals. Am. J. Med. 91, 79S-85S
8. McDonald, M. C., Zacharowski, K., Bowes, J., Cuzzocrea, S., and Thiemermann, C. (1999) Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic. Biol. Med. 27, 493-503
9. Decker, T., Stockinger, S., Karaghiosoff, M., Muller, M., and Kovarik, P. (2002) IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109, 1271-1277
10. O'Shea, J. J., Gadina, M., and Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl., S121-S131
11. Stephanou, A. (2004) Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J. Cell Mol. Med. 8, 519-525
12. Stephanou, A., Brar, B. K., Scarabelli, T. M., Jonassen, A. K., Yellon, D. M., Marber, M. S., Knight, R. A., and Latchman, D. S. (2000) Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J. Biol. Chem. 275, 10002-10008
13. Stephanou, A., Scarabelli, T., Brar, B. K., Nakanishi, Y., Matsumura, M., Knight, R. A., and Latchman, D. S. (2001) Induction of apoptosis and Fas/FasL expression by ischaemia/reperfusion in cardiac myocytes requires serine 727 of the STAT1 but not tyrosine 701. J. Biol. Chem. 276, 28340-28347
14. Stephanou, A., Scarabelli, T., Townsend, P. A., Bell, R., Yellon, D. M., Knight, R. A., and Latchman, D. S. (2002) The carboxylterminal activation domain of the STAT-1 transcription factor enhances ischaemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J. 16, 1841-1843
15. Menegazzi, M., Tedeschi, E., Dussin, D., de Prati, A. C., Cavalieri, E., Mariotto, S., and Suzuki, H. (2001) Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J. 15, 1309-1311
16. Townsend, P. A., Scarabelli, T. M., Pasini, E., Gitti, G., Menegazzi, M., Suzuki, H., Knight, R. A., Latchman, D. S., and Stephanou, A. (2004) Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 18, 1621-1623
17. Stefanutti, G., Pierro, A., Vinardi, S., Spitz, L., and Eaton, S. (2005) Moderate hypothermia protects against systemic oxidative stress in a rat model of intestinal ischemia and reperfusion injury. Shock 24, 159-164
18. Hammond, E. M., Dorie, M. J., and Giaccia, A. J. (2003) ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278, 12207-12213
19. Shen, Y., La Perle, K. M., Levy, D. E., and Darnell, J. E., Jr. (2005) Reduced STAT3 activity in mice mimics clinical disease syndromes. Biochem. Biophys. Res. Commun. 330, 305-309
20. Thiriet, C., and Hayes, J. J. (2005) Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell. 18, 617-622
21. Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S., Lawrence, K. M., Knight, R. A., Hubank, M., Chen, P. L., Latchman, D. S., and Stephanou, A. (2005) STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J. Cell Sci. 118, 1629-1639 Epub 2005 Mar 22.
22. Hilfiker-Kleiner, D., Hilfiker, A., Fuchs, M., Kaminski, K., Schaefer, A., Schieffer, B., Hillmer, A., Schmiedl, A., Ding, Z., and Podewski, E., et al. (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95, 187-195 Epub 2004 Jun 10
23. Shen, Y., Devgan, G., Darnell, J. E., Jr., and Bromberg, J. F. (2001) Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. U. S. A. 98, 1543-1548
24. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsumura, K., and Sano, M., et al. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11, 305-311 Epub 2005 Feb 20
25. Peterson, G. L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356